May 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 241.03 billion in 2025, with a CAGR of 11.26%.
July 2025
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
July 2025
The global antibody therapy market size reached USD 313.47 billion in 2024 and is predicted to surpass around USD 973.60 billion by 2034, with a solid CAGR of 12%.
July 2026
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The global antibody discovery market size was estimated at USD 9.06 billion in 2025 and is projected to hit around USD 22.28 billion by 2035 with a CAGR of 9.42%.
July 2026
The global continuous renal replacement therapy consumables market size was evaluated at USD 920.17 million in 2025 and is predicted to hit around USD 2,069.01 million by 2035, growing at a CAGR of 8.44%.
June 2026
The global physical therapy market size is estimated to hit around USD 52.53 billion by 2035, increasing from USD 26.04 billion in 2025, with a CAGR of 7.27%.
June 2026
The global photothermal therapy patches market size is anticipated at USD 275.29 million in 2025 and is predicted to hit around USD 560.86 million by 2035, growing at a CAGR of 7.38%.
June 2026
The global neutralizing antibody market size is estimated to hit around USD 574.88 billion by 2035 increasing from USD 252.23 billion in 2025, with a CAGR of 8.59%.
June 2026
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The US cell and gene therapy market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 20.00 billion by 2035, growing at a CAGR of 17.21%.
June 2026
The global phage therapy market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.92 billion by 2035, growing at a CAGR of 4.06%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global oncolytic virus therapy market size is evaluated at USD 3.71 billion in 2025 and is predicted to hit around USD 12.31 billion by 2035, growing at a CAGR of 12.74%.
June 2026
The US brachytherapy market size was evaluated at USD 345.22 million in 2025 and is predicted to hit around USD 699.86 million by 2035, growing at a CAGR of 7.32%.
June 2026
The global proton therapy market size surpassed USD 648.64 million in 2025 and is projected to surpass around USD 2,229.88 million by 2035 with a CAGR of 13.14%.
June 2026
The global estrogen replacement therapy market size was evaluated at USD 11.75 billion in 2025 and is predicted to hit around USD 20.49 billion by 2035, growing at a CAGR of 5.72%.
June 2026
The global AAV gene therapy market size was evaluated at USD 2.85 billion in 2025 and is predicted to hit around USD 27.41 billion by 2035, with a CAGR of 25.39%.
June 2026
The US CAR T-cell therapy market size was evaluated at USD 2,299.97 million in 2025 and is predicted to hit around USD 11,510.04 million by 2035, growing at a CAGR of 17.47%.
June 2026
The global salt therapy market size is projected to surpass around USD 20.57 billion by 2035 increasing from USD 8.59 billion in 2025, with a CAGR of 9.12%.
June 2026
The global hormone replacement therapy market size is projected to hit around USD 70.63 billion by 2035 from USD 39.64 billion in 2025 with a notable CAGR of 5.95%.
June 2026
The global cryotherapy market size was valued at USD 10.41 billion in 2025 and it is anticipated to attain around USD 21.14 billion by 2035 with a CAGR of 7.34%.
June 2026
The global radiotherapy market size is calculated at USD 8.56 billion in 2025 and is projected to hit around USD 15.56 billion by 2035 with a CAGR of 6.16%.
June 2026
The global stem cell therapy for neurological disorders market size was evaluated at USD 2.38 billion in 2025 and is predicted to hit around USD 12.67 billion by 2035, growing at a CAGR of 17.90%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com